359 related articles for article (PubMed ID: 17149459)
1. An open-label, multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease.
Ibrahim R; Granton JT; Mehta S
Can Respir J; 2006; 13(8):415-20. PubMed ID: 17149459
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease.
Benza RL; Rayburn BK; Tallaj JA; Coffey CS; Pinderski LJ; Pamoukian SV; Bourge RC
Chest; 2006 Apr; 129(4):1009-15. PubMed ID: 16608951
[TBL] [Abstract][Full Text] [Related]
3. Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review.
Fine N; Dias B; Shoemaker G; Mehta S
Can J Cardiol; 2009 Mar; 25(3):e63-8. PubMed ID: 19279988
[TBL] [Abstract][Full Text] [Related]
4. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects.
Sitbon O; Beghetti M; Petit J; Iserin L; Humbert M; Gressin V; Simonneau G
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():25-31. PubMed ID: 16919007
[TBL] [Abstract][Full Text] [Related]
5. Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect.
D'Alto M; Vizza CD; Romeo E; Badagliacca R; Santoro G; Poscia R; Sarubbi B; Mancone M; Argiento P; Ferrante F; Russo MG; Fedele F; Calabrò R
Heart; 2007 May; 93(5):621-5. PubMed ID: 17135220
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease.
Durongpisitkul K; Jakrapanichakul D; Sompradikul S
J Med Assoc Thai; 2008 Feb; 91(2):196-202. PubMed ID: 18389984
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability evaluation of oral bosentan in adult congenital heart disease associated pulmonary arterial hypertension: a systematic review and meta-analysis.
Guo L; Liu YJ; Xie ZL
Eur Rev Med Pharmacol Sci; 2014; 18(5):638-45. PubMed ID: 24668703
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease.
Monfredi O; Griffiths L; Clarke B; Mahadevan VS
Am J Cardiol; 2011 Nov; 108(10):1483-8. PubMed ID: 21943933
[TBL] [Abstract][Full Text] [Related]
9. Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease.
Apostolopoulou SC; Manginas A; Cokkinos DV; Rammos S
Heart; 2005 Nov; 91(11):1447-52. PubMed ID: 15761050
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?
van Loon RL; Hoendermis ES; Duffels MG; Vonk-Noordegraaf A; Mulder BJ; Hillege HL; Berger RM
Am Heart J; 2007 Oct; 154(4):776-82. PubMed ID: 17893008
[TBL] [Abstract][Full Text] [Related]
11. Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study.
Apostolopoulou SC; Manginas A; Cokkinos DV; Rammos S
Heart; 2007 Mar; 93(3):350-4. PubMed ID: 16980516
[TBL] [Abstract][Full Text] [Related]
12. Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome.
D'Alto M; Romeo E; Argiento P; D'Andrea A; Sarubbi B; Correra A; Scognamiglio G; Papa S; Bossone E; Calabrò R; Vizza CD; Russo MG
Int J Cardiol; 2013 Apr; 164(3):323-6. PubMed ID: 21802156
[TBL] [Abstract][Full Text] [Related]
13. [Outcome of oral bosentan in children with congenital heart disease associated pulmonary arterial hypertension].
Xu ZM; Zhu LM; Cai XM; Ji G; Liu JF; Su ZK
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2106-9. PubMed ID: 20058613
[TBL] [Abstract][Full Text] [Related]
14. Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease.
Baptista R; Castro G; da Silva AM; Monteiro P; Providência LA
Rev Port Cardiol; 2013 Feb; 32(2):123-9. PubMed ID: 23351920
[TBL] [Abstract][Full Text] [Related]
15. Initial experience with bosentan (Tracleer) as treatment for pulmonary arterial hypertension (PAH) due to congenital heart disease in infants and young children.
Gilbert N; Luther YC; Miera O; Nagdyman N; Ewert P; Berger F; Lange PE; Schulze-Neick I
Z Kardiol; 2005 Sep; 94(9):570-4. PubMed ID: 16142516
[TBL] [Abstract][Full Text] [Related]
16. Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.
Benza RL; Rayburn BK; Tallaj JA; Pamboukian SV; Bourge RC
Chest; 2008 Jul; 134(1):139-45. PubMed ID: 18403673
[TBL] [Abstract][Full Text] [Related]
17. Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study.
Steiner MK; Preston IR; Klinger JR; Criner GJ; Waxman AB; Farber HW; Hill NS
Chest; 2006 Nov; 130(5):1471-80. PubMed ID: 17099026
[TBL] [Abstract][Full Text] [Related]
18. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
Lunze K; Gilbert N; Mebus S; Miera O; Fehske W; Uhlemann F; Mühler EG; Ewert P; Lange PE; Berger F; Schulze-Neick I
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():32-8. PubMed ID: 16919008
[TBL] [Abstract][Full Text] [Related]
19. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.
Denton CP; Humbert M; Rubin L; Black CM
Ann Rheum Dis; 2006 Oct; 65(10):1336-40. PubMed ID: 16793845
[TBL] [Abstract][Full Text] [Related]
20. Bosentan therapy for pulmonary arterial hypertension.
Rubin LJ; Badesch DB; Barst RJ; Galie N; Black CM; Keogh A; Pulido T; Frost A; Roux S; Leconte I; Landzberg M; Simonneau G
N Engl J Med; 2002 Mar; 346(12):896-903. PubMed ID: 11907289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
